2019年度Journal Club 汇报文献汇总 | ||||
| 时间 | 汇报人 | 题目 | 杂志名称 | 影响因子 |
| 20190416 | 陈玲 | 肿瘤免疫应答中TCR表达谱的分析与研究 (review) | ||
| 20190423 | 咸娜 | Clonal Deletion of Tumor-Specific T Cells by Interferon-g Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade | IMMUNITY | 21.522 |
| 20190508 | 胡妍 | Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance | Scientific Reports | 4.011 |
| 20190514 | 车耀健 | CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB | Nature Communications | 11.878 |
| 20190522 | 梅文枫 | Application of 13C flux analysis to identify high-productivity CHO metabolic phenotypes | METABOLIC ENGINEERING | 7.808 |
| 20190529 | 周琳琳 | Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory | CELL | 36.216 |
| 20190605 | 郭晴晴 | Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade | NATURE | 43.070 |
| 20190612 | 潘剑峰 | Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses | SCIENCE | 41.037 |
| 20190626 | 何健伟 | Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors | CANCER CELL | 23.916 |
| 20190703 | 胡莉 | Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy | IMMUNITY | 21.522 |
| 20190828 | 冯睿 | Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model | Science Translational Medicine | 17.161 |
| 20190904 | 何柏霖 | Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis | IMMUNITY | 21.522 |
| 20190911 | 王珺 | PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance | NATURE IMMUNOLOGY | 23.530 |
| 20190918 | 赖金枝 | T cell stemness and dysfunction in tumors are triggered by a common mechanism | SCIENCE | 41.037 |
| 20190925 | 张金栋 | Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials | Science Translational Medicine | 17.161 |
| 20191009 | 王春华 | Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies | Science Translational Medicine | 17.161 |
| 20191016 | 吴继春 | Ultrasound imaging of gene expression in mammalian cells | SCIENCE | 41.037 |
| 20191030 | 罗安 | High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-b Cytokine Activation | IMMUNITY | 21.522 |
| 20191106 | 陈梅清 | Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer | NATURE IMMUNOLOGY | 23.530 |
| 20191113 | 陈远贵 | VISTA is an acidic pH-selective ligand for PSGL-1 | NATURE | 43.070 |
| 20191120 | 陈权 | MHC-II neoantigens shape tumour immunity and response to immunotherapy | NATURE | 43.070 |
| 20191127 | 兰海林 | Immunity to commensal papillomaviruses protects against skin cancer | NATURE | 43.070 |
| 20191211 | 万晓叶 | Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling | CANCER CELL | 23.916 |
| 20191218 | 游镇玮 | A Single -Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer | CELL | 36.216 |
| 20191225 | 李莉君 | PD-L1:CD80 Cis-Heterodimer Triggers the Costimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways | IMMUNITY | 21.522 |
| 平均影响因子 | 26.896 | |||

